Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v4-FR
Language French French
Date Updated 2023-06-09 2023-05-12
Drug Identification Number 02512645 02512645
Brand name APO-DOXYCYCLINE MR APO-DOXYCYCLINE MR
Common or Proper name DOXYCYCLINE DOXYCYCLINE
Company Name APOTEX INC APOTEX INC
Ingredients DOXYCYCLINE DOXYCYCLINE
Strength(s) 40MG 40MG
Dosage form(s) CAPSULE (IMMEDIATE AND DELAYED RELEASE) CAPSULE (IMMEDIATE AND DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 28 BLS 28 BLS
ATC code J01AA J01AA
ATC description TETRACYCLINES TETRACYCLINES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-02 2023-05-02
Estimated end date 2023-06-09 2023-05-19
Actual end date 2023-06-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments